title: FOP-iMSC TGFB1
design: Comparison of gene expression in resFOP and FOP-iMSCs after treatment with TGF- family ligands (control: no treatment, 100 ng/mL of BMP-7, BMP-9, or Activin-A, or 10 ng/mL of TGF-1 or TGF-3 for 72 h).